Growth hormone and TSH deficiency after [177Lu] Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case

被引:0
|
作者
van Wessel, Karen [1 ]
de Keizer, Bart [2 ]
Dierselhuis, Miranda [2 ]
van Santen, Hanneke [1 ]
机构
[1] Wilhelmina Childrens Hosp, Utrecht, Netherlands
[2] Princess Maxima Ctr, Utrecht, Netherlands
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
RFC13.5
引用
收藏
页码:120 / 120
页数:1
相关论文
共 50 条
  • [1] Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
    Javian C. Malcolm
    Nadia Falzone
    Jennifer E. Gains
    Matthew D. Aldridge
    David Mirando
    Boon Q. Lee
    Mark N. Gaze
    Katherine A. Vallis
    EJNMMI Physics, 9
  • [2] Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
    Malcolm, Javian C.
    Falzone, Nadia
    Gains, Jennifer E.
    Aldridge, Matthew D.
    Mirando, David
    Lee, Boon Q.
    Gaze, Mark N.
    Vallis, Katherine A.
    EJNMMI PHYSICS, 2022, 9 (01)
  • [3] p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
    Hanna Berglund
    Sara Lundsten Salomonsson
    Tabassom Mohajershojai
    Fernando Jose Ferrer Gago
    David P. Lane
    Marika Nestor
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 768 - 778
  • [4] p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
    Berglund, Hanna
    Salomonsson, Sara Lundsten
    Mohajershojai, Tabassom
    Gago, Fernando Jose Ferrer
    Lane, David P.
    Nestor, Marika
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 768 - 778
  • [5] Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE
    Rousseau, Etienne
    Lau, Joseph
    Zhang, Zhengxing
    Uribe, Carlos F.
    Kuo, Hsiou-Ting
    Zhang, Chengcheng
    Zeisler, Jutta
    Colpo, Nadine
    Lin, Kuo-Shyan
    Benard, Francois
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 66 : 10 - 17
  • [6] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Nanabala, Raviteja
    Pillai, Maroor Raghavan Ambikalmajan
    Gopal, Buvaneswari
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 56 (06) : 313 - 322
  • [7] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Raviteja Nanabala
    Maroor Raghavan Ambikalmajan Pillai
    Buvaneswari Gopal
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 313 - 322
  • [8] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Staanum, Peter Frohlich
    Frellsen, Anders Floor
    Olesen, Marie Louise
    Iversen, Peter
    Arveschoug, Anne Kirstine
    EJNMMI PHYSICS, 2021, 8 (01)
  • [9] Extravasation After [177Lu]Lu-HA-DOTATATE Therapy
    de Vries-Huizing, Daphne M. V.
    Cheung, Zing J.
    Hendrikx, Jeroen J. M. A.
    Donswijk, Maarten L.
    Versleijen, Michelle W. J.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (05) : 454 - 456
  • [10] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Peter Frøhlich Staanum
    Anders Floor Frellsen
    Marie Louise Olesen
    Peter Iversen
    Anne Kirstine Arveschoug
    EJNMMI Physics, 8